In human acute leukemia, FLT3 is expressed on the surface of the leukemic cells in 70–90% acute myeloid leukemia (AML) patients and most B-acute lymphoblastic leukemia (B-ALL) [1], [2], [3]. This evidence concerns the gene FLT3 and acute myeloid leukemia.